Literature DB >> 165031

Vitamin D metabolism and parathyroid function in man.

E B Mawer, J Backhouse, L F Hill, G A Lumb, P De Silva, C M Taylor, S W Stanbury.   

Abstract

1. The metabolism of an intravenous pulse dose of double-isotope-labelled cholecalciferol has been studied in control subjects with widely differing states of vitamin D nutrition and in patients with primary disorders of parathyroid function. 2. The formation of labelled 1,25-dihydroxy-cholecalciferol [1,25-(OH)2D3] and labelled 24,25-dihydroxycholecalciferol [24,25-(OH)2D3] has been related to the prevailing concentrations in serum of 25-hydroxycholecalciferol [25-(OH)D3], immunoreactive parathyroid hormonel, calcium and orthophosphate (Pi). 3. In control subjects with relative vitamin D deficiency [serum 25-(OH)2D3 was related inversely to the serum 25-(OH)D3 and serum calcium, and directly to serum immunoreactive parathyroid hormone. No formation of 1,25-(OH)2D3 was detectable to form labelled 24,25(OH)2D3 preferentially. 4. No control subject produced significant amounts of both labelled 1,25-(OH)2D3 and labelled 24,25-(OH)2D3 simultaneously. 5. All subjects with primary hyperparathyroidism produced significant amounts of labelled 1,25-(OH)2D3 and labelled 24,25-(OH)2D3 simultaneously; the renal turnover of 25-(OH)D3 was apparently greater than in nutritionally matched controls. Serum labelled 1,25-(OH)2D3 in this disease was not correlated with serum 25-(OH)D3, immunoreactive parathyroid hormone, calcium or Pi. Production of labelled 24,25-(OH)2D3 was inappropriately high for the prevailing nutritional state. 6. The indirectly estimated their concentration of 1,25-(OH)2D3 showed only a fourfold variation in control subjects (45-180 pmol/l), compatible with its having a regulated hormonal function. 7. The data suggest that the production of 1,25-(OH)2D3 from a pulse dose of cholecalciferol is normally regulated, directly or indirectly, by the parathyroid hormone.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165031     DOI: 10.1042/cs0480349

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  21 in total

1.  A case of resolving idiopathic hypoparathyroidism.

Authors:  L Ostlere; J Reeve
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

2.  Vitamin D metabolism and the response to 1,25-dihydroxycholecalciferol in osteoporosis.

Authors:  M Davies; E B Mawer; P H Adams
Journal:  Calcif Tissue Res       Date:  1977-05

3.  A synergistic interaction between the teratogenic effect of trypan blue and dietary deficiency in the rat.

Authors:  R G Lendon
Journal:  Experientia       Date:  1978-04-15

4.  Kinetic analysis of 25-hydroxyvitamin D3 metabolism in strontium-induced rickets in the chick.

Authors:  J L Omdahl; G Jelinek; R P Eaton
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

5.  Competitive protein-binding assay for 24,25-dihydroxycholecalciferol.

Authors:  C M Taylor; P De Silva; S E Hughes
Journal:  Calcif Tissue Res       Date:  1977-05

6.  1-Alpha-hydroxy vitamin D3 in primary hyperparathyroidism.

Authors:  I T Boyle; I Fogelman; G H Beastall; S Joffe; B Boyce
Journal:  Br Med J       Date:  1979-03-24

7.  Diagnosis of subclinical rickets.

Authors:  J M Pettifor; J M Isdale; J Sahakian; J D Hansen
Journal:  Arch Dis Child       Date:  1980-02       Impact factor: 3.791

8.  Reduction of circulating 25-hydroxyvitamin D by antipyrine.

Authors:  P F Wilmana; M J Brodie; J C Mucklow; H S Fraser; E L Toverud; D S Davies; C T Dollery; C J Hillyard; I Macintyre; B K Park
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

9.  Vitamin D deficiency, osteomalacia, and primary biliary cirrhosis. Response to orally administered vitamin D3.

Authors:  M Davies; E B Mawer; H J Klass; G A Lumb; J L Berry; T W Warnes
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

10.  Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man?

Authors:  J A Kanis; T Cundy; M Bartlett; R Smith; G Heynen; G T Warner; R G Russell
Journal:  Br Med J       Date:  1978-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.